NCT00423514 2022-12-27Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other DiseaseMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed38 enrolled 12 charts
NCT00003398 2019-10-17Bone Marrow Transplantation in Treating Patients With Hematologic CancerUniversity of Maryland, BaltimorePhase 4 Completed45 enrolled
NCT00450983 2017-05-24Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesFred Hutchinson Cancer CenterPhase 2 Terminated1 enrolled 5 charts